Biotech giant attempts to own biosphere
Many individuals are aware that biotech has developed a seed monopoly largely by patenting genetically modified organisms, but not everyone realizes that Monsanto tried to patent a tomato that had no biotech traits. Now, the European Patent Office (EPO), with help from an international coalition, No Patents on Seeds!, has revoked Monsanto’s fraudulent patent and claim to tomatoes that are naturally resistant to a fungal disease called botrytis.
These natural, non-GMO tomatoes, like many healthy plants, have a natural resistance to certain pests. In this case, a fungal disease, but this is not a novel phenomenon. Why Monsanto would try to claim they created it is about as believable as Syngenta or Dow saying they invented the sun.
Though plant breeders can help plants develop this natural pest resistance, much of it is innate – the same as our own immune systems. When individual plants reproduce, they pass along exceptional combinations of genes to their offspring. Varying environments (such as cold, or dry, moist or breezy) favor individuals with different physical and behavioral traits. Individual plants with genes that improve their survival will be more likely to pass along these genes compared to the rest of the population.